Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Reneo Pharmaceuticals, Inc. | Chief Financial Officer | Common Stock | 36.6K | $230K | $6.28 | Dec 10, 2021 | Direct |
Reneo Pharmaceuticals, Inc. | Chief Financial Officer | Stock option (right to buy) | 100K | Dec 10, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RPHM | Reneo Pharmaceuticals, Inc. | Dec 10, 2021 | 2 | $0 | 4 | Dec 14, 2021 | Chief Financial Officer |
RPHM | Reneo Pharmaceuticals, Inc. | Aug 25, 2021 | 1 | $37.2K | 4 | Aug 26, 2021 | Chief Financial Officer |